Rituximab combined with low-dose, short-course glucocorticoids versus standard glucocorticoid therapy in adults with newly diagnosed minimal change disease: A retrospective cohort study
Néphrologie & Thérapeutique · 01.10.2026 · 22 (6) · 1-12
DOI: 10.1684/ndt.2026.203 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Néphrologie & Thérapeutique, erschienen am 01.10.2026. Verfasst von Bingqing Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: These authors contributed equally to this work and share first authorship. Hauptthemen laut MEDLINE: Rituximab, Glucocorticoids, Nephrosis, Lipoid, Methylprednisolone.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- These authors contributed equally to this work and share first authorship.
- Department of nephrology, the affiliated hospital of Putian University, Putian, Fujian, China
Zitieren
APA
Liu, B., Lin, R., Lin, Y., & Xu, H. (2026). Rituximab combined with low-dose, short-course glucocorticoids versus standard glucocorticoid therapy in adults with newly diagnosed minimal change disease: A retrospective cohort study. Néphrologie & Thérapeutique, 22(6), 1-12. https://doi.org/10.1684/ndt.2026.203
Vancouver
Liu B, Lin R, Lin Y, Xu H. Rituximab combined with low-dose, short-course glucocorticoids versus standard glucocorticoid therapy in adults with newly diagnosed minimal change disease: A retrospective cohort study. Néphrologie & Thérapeutique. 2026;22(6):1-12. doi:10.1684/ndt.2026.203
BibTeX
@article{Liu2026,
author = {Liu, Bingqing and Lin, Rongrong and Lin, Yuanjie and Xu, Haishan},
title = {Rituximab combined with low-dose, short-course glucocorticoids versus standard glucocorticoid therapy in adults with newly diagnosed minimal change disease: A retrospective cohort study},
journal = {Néphrologie & Thérapeutique},
year = {2026},
volume = {22},
number = {6},
pages = {1--12},
doi = {10.1684/ndt.2026.203}
}
EUVIMED